全文获取类型
收费全文 | 4973篇 |
免费 | 436篇 |
国内免费 | 9篇 |
学科分类
医药卫生 | 5418篇 |
出版年
2021年 | 55篇 |
2020年 | 51篇 |
2019年 | 51篇 |
2018年 | 65篇 |
2017年 | 78篇 |
2016年 | 57篇 |
2015年 | 91篇 |
2014年 | 136篇 |
2013年 | 186篇 |
2012年 | 222篇 |
2011年 | 225篇 |
2010年 | 172篇 |
2009年 | 130篇 |
2008年 | 200篇 |
2007年 | 231篇 |
2006年 | 199篇 |
2005年 | 199篇 |
2004年 | 224篇 |
2003年 | 216篇 |
2002年 | 225篇 |
2001年 | 207篇 |
2000年 | 202篇 |
1999年 | 140篇 |
1998年 | 42篇 |
1997年 | 49篇 |
1996年 | 38篇 |
1995年 | 56篇 |
1994年 | 42篇 |
1993年 | 58篇 |
1992年 | 96篇 |
1991年 | 116篇 |
1990年 | 115篇 |
1989年 | 107篇 |
1988年 | 100篇 |
1987年 | 89篇 |
1986年 | 90篇 |
1985年 | 84篇 |
1984年 | 64篇 |
1983年 | 65篇 |
1982年 | 41篇 |
1980年 | 28篇 |
1979年 | 56篇 |
1978年 | 48篇 |
1977年 | 28篇 |
1975年 | 33篇 |
1974年 | 34篇 |
1973年 | 30篇 |
1972年 | 35篇 |
1971年 | 28篇 |
1970年 | 30篇 |
排序方式: 共有5418条查询结果,搜索用时 15 毫秒
1.
2.
Aneesh Dhorepatil Somedeb Ball Raktim K. Ghosh Meera Kondapaneni Carl J. Lavie 《The American journal of medicine》2019,132(3):312-324
Inflammation has proven in multiple studies to be responsible for the progression of cardiometabolic diseases and malignancies. The interleukin family has been critically associated with progression of atherosclerosis, insulin resistance, and various malignancies. Given the advent of pharmacologic interleukin-1 (IL-1) inhibition, this pathway can potentially be targeted to improve outcomes. In the recently concluded Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) trial, investigators looked at the potential role of IL-1 (especially IL-1β) inhibition in halting the progression of atherosclerosis. In the subset analysis of the data from this trial, IL-1β inhibition with canakinumab was found to have beneficial effects in other cardiometabolic diseases characterized by inflammation, like diabetes, stroke, and chronic kidney disease, and also in patients with lung cancer. In this article, we will try to review the current literature on the role of canakinumab in the treatment of cardiometabolic diseases and malignancies. 相似文献
3.
IntroductionInterprofessional learning (IPL) is a vital aspect of training in radiation oncology professions, yet is rarely delivered to those professionals who work most closely together in clinical practice. Scenario-based learning using simulation facilities provides a unique opportunity to facilitate this learning and this project aimed to determine the impact and value of this initiative.MethodsSmall groups comprising post-graduate diploma pre-registration therapeutic radiographers, medical physics trainees and radiation oncology registrars were challenged with 4 plausible and challenging radiotherapy scenarios within an academic simulation centre. Pre- and post-event completion of the “Readiness for Interprofessional Learning Scale” measured impact and a Likert-style survey gathered feedback from participants.ResultsThe session increased participants' teamwork and collaboration skills as well as strengthening professional identities. Participants reported high levels of enjoyment related to collaborative working, communication and observing other professionals deploying their technical skills and specialist knowledge.ConclusionAlthough beneficial, simulated scenarios offering equal opportunities for engagement across the professions are challenging to plan and timetabling issues between the 3 groups present significant difficulties. The safe environment and unique opportunity for these groups to learn together was particularly well received and future oncology-specific simulated scenario sessions are planned with larger cohorts.Implications for practiceSimulated scenario training can be used to improve team working across the radiotherapy interprofessional team and may have wider use in other specialist interdisciplinary team development. 相似文献
4.
Lino Möhrmann Martina K. Zowada Hendrik Strakerjahn Christine Siegl Annette Kopp-Schneider Damir Krunic Dirk Strunk Martin Schneider Mark Kriegsmann Katharina Kriegsmann Friederike Herbst Claudia R. Ball Hanno Glimm Sebastian M. Dieter 《International journal of cancer. Journal international du cancer》2020,147(2):519-531
Disseminated tumor cells (dTCs) can frequently be detected in the bone marrow (BM) of colorectal cancer (CRC) patients, raising the possibility that the BM serves as a reservoir for metastatic tumor cells. Identification of dTCs in BM aspirates harbors the potential of assessing therapeutic outcome and directing therapy intensity with limited risk and effort. Still, the functional and prognostic relevance of dTCs is not fully established. We have previously shown that CRC cell clones can be traced to the BM of mice carrying patient-derived xenografts. However, cellular interactions, proliferative state and tumorigenicity of dTCs remain largely unknown. Here, we applied a coculture system modeling the microvascular niche and used immunofluorescence imaging of the murine BM to show that primary CRC cells migrate toward endothelial tubes. dTCs in the BM were rare, but detectable in mice with xenografts from most patient samples (8/10) predominantly at perivascular sites. Comparable to primary tumors, a substantial fraction of proliferating dTCs was detected in the BM. However, most dTCs were found as isolated cells, indicating that dividing dTCs rather separate than aggregate to metastatic clones—a phenomenon frequently observed in the microvascular niche model. Clonal tracking identified subsets of self-renewing tumor-initiating cells in the BM that formed tumors out of BM transplants, including one subset that did not drive primary tumor growth. Our results indicate an important role of the perivascular BM niche for CRC cell dissemination and show that dTCs can be a potential source for tumor relapse and tumor heterogeneity. 相似文献
5.
6.
7.
8.
José A. Lorente Pablo Cardinal-Fernández Diego Muñoz Fernando Frutos-Vivar Arnaud W. Thille Carlos Jaramillo Aida Ballén-Barragán José M. Rodríguez Oscar Peñuelas Guillermo Ortiz José Blanco Bruno Valle Pinheiro Nicolás Nin María del Carmen Marin Andrés Esteban Taylor B. Thompson 《Intensive care medicine》2015,41(11):1921-1930
9.
10.